Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biostem Technologies Inc (BSEM)

Biostem Technologies Inc (BSEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 282,523
  • Shares Outstanding, K 16,619
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ 0 M
  • EBITDA $ 0 M
  • 60-Month Beta -0.62
  • Price/Sales 17.18
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 25.37
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings $0.32 on 11/12/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.3900 +44.86%
on 11/19/24
17.9400 -8.03%
on 12/16/24
+2.9000 (+21.32%)
since 11/18/24
3-Month
9.6100 +71.70%
on 10/02/24
28.2565 -41.61%
on 11/12/24
+6.7400 (+69.06%)
since 09/18/24
52-Week
4.4100 +274.15%
on 01/29/24
28.2565 -41.61%
on 11/12/24
+11.3100 (+217.92%)
since 12/18/23

Most Recent Stories

More News
BioStem Announces Notice of Allowance for U.S. Patent Application for Sterile Human Placental Allografts

BSEM : 16.5000 (-2.94%)
BioStem Technologies Signs Letter of Intent to Acquire Wound Care Products and Technologies from ProgenaCare Global

BSEM : 16.5000 (-2.94%)
Small and Micro-Cap Movers: Your Daily Digest of High-Impact News From High-Growth Companies Rising in Popularity

WealthyVC.com scans North America’s 10,000+ publicly listed stocks across all seven exchanges to find the market-moving news that matters. Our focus is on quality, liquid, growth-oriented companies in...

BCHT : 0.5500 (+1.85%)
MNTS : 8.09 (unch)
ONTF : 6.51 (-2.54%)
RELL : 14.47 (+0.07%)
BSEM : 16.5000 (-2.94%)
MOGO : 1.3200 (-8.33%)
TRAK : 22.52 (-8.27%)
BioStem Technologies Reports Record Third Quarter 2024 Revenue of $82.6 Million

BSEM : 16.5000 (-2.94%)
BioStem Technologies Initiates Nationwide Launch of Vendaje AC® with Venture Medical Following Established Reimbursement in All Medicare Administrative Contractor (MAC) Regions

BSEM : 16.5000 (-2.94%)
BioStem Technologies to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

BSEM : 16.5000 (-2.94%)
BioStem Technologies to Present at the LD Micro Main Event XVII on Wednesday, October 30, 2024, at 9:30 AM PT

Presentation to be webcast, with management participating in 1-on-1 meetings at the Luxe Sunset Boulevard Hotel in Los AngelesPompano Beach, Florida--(Newsfile Corp. - October 23, 2024) - BioStem Technologies,...

BSEM : 16.5000 (-2.94%)
BioStem Technologies Reports Breakthrough Results in a Diabetic Foot Ulcer Wound Closure Study Comparing BioREtain® to Standard of Care Treatment

BSEM : 16.5000 (-2.94%)
BioStem Technologies Establishes National Pricing for Vendaje AC® from the Center for Medicare Services and Provides Reimbursement in All MAC Regions

BSEM : 16.5000 (-2.94%)
BioStem Technologies Inc. In A Race To The Top With Innovative Wound-Care Treatments

Miami, Florida--(Newsfile Corp. - July 16, 2024) - Innovation is the lifeblood of the MedTech sector. Literally. Discoveries made are more than value drivers for the companies behind them; they can be...

BSEM : 16.5000 (-2.94%)

Business Summary

BioStem Technologies Inc. is a regenerative medicine company. It focused on the development, manufacture and commercialization of placental derived biologics. The company's portfolio of brands includes VENDAJE(R), VENDAJE AC(R) and VENDAJE OPTIC(R). BioStem Technologies Inc. is based in POMPANO BEACH,...

See More

Key Turning Points

3rd Resistance Point 17.9667
2nd Resistance Point 17.6733
1st Resistance Point 17.0867
Last Price 16.5000
1st Support Level 16.2067
2nd Support Level 15.9133
3rd Support Level 15.3267

See More

52-Week High 28.2565
Fibonacci 61.8% 19.1471
Last Price 16.5000
Fibonacci 50% 16.3333
Fibonacci 38.2% 13.5194
52-Week Low 4.4100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar